U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07682584) titled 'Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective Analysis' on June 28.
Brief Summary: This retrospective study aims to identify predictive factors for biochemical recurrence (BCR) in patients with localized prostate cancer who underwent robot-assisted radical prostatectomy (RARP). BCR is defined as a rise in prostate-specific antigen (PSA) levels after surgery, which may indicate residual or recurrent disease.
We will analyze clinical, imaging, and pathological data from patients treated at Fujian Medical University Affiliated First Hospital between January 2024 and May 2026. Key variables include preopera...